Tags : Biofourmis

Top 20 Innovative Digital Therapeutics Companies of 2019

The recent decades have shown an accelerated development and evolution in the technology world, leading to unexpected growth in digital health companies. The Digital Therapeutics companies aid patients to schedule appointments, view medical records and seek medical advice without visiting clinics or hospitals. With the aid of health information technology, wearable devices, telehealth, telemedicine, and […]Read More

Chugai and Biofourmis Collaborate to Develop Solutions for Digitally Measuring

Shots: The collaboration will deploy Biofourmis’ Biovitals platform to co-develop a novel digital technology for the objective assessment of pain using biosensors and AI-based algorithms. The solutions will be validated in the global study that enrolls 120+ endometriosis patients The digital solution for managing patients with endometriosis in an ambulatory setting will include a wearable, […]Read More

PharmaShots’ Key Highlights of Fourth Quarter 2019

1. Pfizer Launched its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019 Date – Oct 01, 2019 Product – Zirabev (biosimilar, bevacizumab) The biosimilar was launched in the US on Dec 31, 2019 following the settlement between Genentech and Pfizer granting all global rights of the product to the Pfizer. In Sept […]Read More

PharmaShots Weekly Snapshot (November 18-22, 2019)

1.  Lupin Launches Smart Device for Metered-Dose Inhalers to Support Treatment of Respiratory Diseases in India Published: Nov 22, 2019 | Tags: Lupin, Launches, Smart Device, Metered-Dose Inhalers, Support, Treatment, Respiratory Diseases, India 2. BioMarin Reports Submission of MAA to EMA for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A Published: Nov 21, 2019 | Tags: BioMarin, […]Read More

Novartis Collaborates with Biofourmis To Offer Digital Therapeutics for Managing

Shots: Novartis will access Biofourmis’ lead digital therapeutics, BiovitalsHF to manage patients with heart failure across Asia, with a potential plan to expand it globally The focus of the collaboration is to improve clinical outcomes utilizing Biofourmis’ BiovitalsHF along with Biovitals Analytics Engine to identify early signs of HF exacerbations, enabling early interventions in patients […]Read More

PharmaShots Weekly Snapshot (October 07-11, 2019)

OraSure Technologies’ Rapid Diagnostic OraQuick Ebola Rapid Antigen Test Receives the US FDA Marketing Approval for Detection of Ebola Virus Antigens Published: Oct 10, 2019 | Tags: Diagnostic, Oraquick Ebola Rapid Antigen Test, Orasure Technologies, Rapid, Receives, The US FDA, Marketing, Approval, Detection, Ebola Virus Antigens 2. Alnylam Reports Submission of MAA to Brazilian Health Regulatory […]Read More

Biofourmis’ Biovitals Analytics Engine Receives FDA’s 510(k) Clearance for Ambulatory

Shots: The US FDA has approved machine learning and AI-based Biofourmis’ Biovitals Analytics Engine as a medical device for ambulatory physiological monitoring  The approval follows the approval of its Rhythm Analytics platform, cloud-based software for automated interpretation of 15+ types of cardiac arrhythmias in May’2019. The approval establishes the AI-powered solution as the foundation for […]Read More